Highnoon Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Highnoon Laboratories Limited with three other
pharmaceutical manufacturers in Asia:
Korean Drug Co Ltd
of South Korea
sales of 55.31 billion Korean Won [US$48.67 million]
Caplin Point Laboratories Limited
(3.08 billion Indian Rupees [US$48.12 million]
of which 100%
was Pharmaceutical), and
based in India
(3.04 billion Indian Rupees [US$47.48 million]
Highnoon Laboratories Limited reported sales of 5.07 billion Pakistan Rupees (US$48.12 million)
December of 2016.
increase of 15.1%
versus 2015, when the company's sales were 4.40 billion Pakistan Rupees.
This was the fourth straight year of sales growth at Highnoon Laboratories Limited.